Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;20(2):1035-1042.
doi: 10.1016/j.jds.2024.11.021. Epub 2024 Dec 3.

A retrospective study on odontogenic and non-odontogenic medication-related osteonecrosis of the jaw: Potential differences in clinical features and treatment outcomes

Affiliations

A retrospective study on odontogenic and non-odontogenic medication-related osteonecrosis of the jaw: Potential differences in clinical features and treatment outcomes

Mizuho Ohnuma et al. J Dent Sci. 2025 Apr.

Abstract

Background/purpose: Local infections, such as periodontal disease or apical lesions, and invasive dental procedures, such as tooth extraction, are thought to trigger medication-related osteonecrosis of the jaw (MRONJ) development. However, some cases of MRONJ develop without any obvious odontogenic triggers. We conducted a retrospective study to clarify the characteristics of non-odontogenic MRONJ.

Materials and methods: We retrospectively reviewed data of 229 patients with mandibular MRONJ who underwent surgery. Based on imaging findings, we classified MRONJ as odontogenic MRONJ involving a dental infection and non-odontogenic MRONJ with no dental involvement. Clinical and imaging findings and treatment outcomes of both types of MRONJ were compared.

Results: Overall, 193 patients were classified as having odontogenic MRONJ and 36 as having non-odontogenic MRONJ. Non-odontogenic MRONJ was slightly more common among patients with malignancies who received denosumab; however, the difference was not significant. Univariate and multivariate analyses showed that patients with MRONJ with non-odontogenic triggers had significantly poorer treatment outcomes than their counterparts.

Conclusion: Non-odontogenic MRONJ exists without the involvement of odontogenic infection as a cause of MRONJ. Compared with that in odontogenic MRONJ, the treatment outcome in non-odontogenic MRONJ is poor. Further studies are required to clarify the true nature of non-odontogenic MRONJ.

Keywords: Infection; MRONJ; Non-odontogenic; Odontogenic; Trigger.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. This research received no external funding.

Figures

Figure 1
Figure 1
Odontogenic MRONJ. Osteolysis and sequestrum separation were seen in continuity with the periapical radiolucent area. A: panoramic X-ray, B: CT of frontal sections, C: CT of axial sections.
Figure 2
Figure 2
Non-odontogenic MRONJ. A, B: There was an ulceration under the denture base that reached the bone, and a radiolucent area was seen from the alveolar surface to the upper mandibular canal. C, D: There was no bone exposure or fistula in the oral cavity, but a cutaneous fistula was found in the lower jaw. There was no tooth with a source of infection and no osteolysis in the alveolar region, but there was extensive periosteal reaction at the inferior margin of the mandible.
Figure 3
Figure 3
The cumulative cure rate of the all patients. Three-year cure rate was 84.0 %.
Figure 4
Figure 4
Factors related to the treatment outcome. Along with malignancy and mixed-type osteosclerosis, non-odontogenic trigger was associated with poor treatment outcome.

References

    1. Ruggiero S.L., Dodson T.B., Aghaloo T., Carlson E.R., Ward B.B., Kademani D. American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022;80:920–943. - PubMed
    1. Soutome S., Hayashida S., Funahara M., et al. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: is tooth extraction a risk factor? PLoS One. 2018;13 - PMC - PubMed
    1. Soutome S., Otsuru M., Hayashida S., et al. Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients. Sci Rep. 2021;11 - PMC - PubMed
    1. Lesclous P., Abi Najm S., Carrel J.P., et al. Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone. 2009;45:843–852. - PubMed
    1. Sakamoto Y., Sawada S., Kojima Y. Pathogenesis of medication-related osteonecrosis of the jaw: odontogenic infection-preceding type and osteonecrosis-preceding type. Cureus. 2024;16 - PMC - PubMed

LinkOut - more resources